Sai Parenteral’s IPO Price Band Set at ₹372 to ₹392 per Share, Targets ₹285 Crore Fresh Issue
Company Files RHP with SEBI and Stock Exchanges
Sai Parenteral’s Ltd, a diversified pharmaceutical formulation company, has announced the price band for its upcoming Initial Public Offering, setting it...
business expansion
contractdevelopmentandmanufacturingorganisation
corporate finance
equity shares
financial
global formulations
initial public offering
injectable products
investment
ipo
oral solid dosage formulations
pharmaceutical formulation
red herring prospectus
sai parenteral's ltd
securities and exchange board of india
stock exchange
